JSON

Strain sc|0030195

Name

Cutibacterium acnesT

Strain numbers

ATCC 6919 = CCUG 1794 = CIP 53.117 = DSM 1897 = JCM 6425 = LMG 16711 = NCTC 737 = NRRL B-4224 = VKM Ac-1450
This strain is associated as type material for multiple names:

StrainInfo: SI-ID 389260 T

Taxon
Cutibacterium acnesT
Sample
Human, facial acne (GB)
Cultures (18)
LMG 3591 = ATCC 6919 = CCRC 10723 = CCUG 1794 = DSM 1897 = JCM 6425 = LMG 16711 = NCTC 737 = VKM Ac-1450 = CIP 53.117 = KCTC 3314 = KCTC 5008 = AS 1.5003 = NRRL B-4224 = BCRC 10723 = CCT 2592 = CECT 5684 = CGMCC 1.5003
Other Designations (7)
LMG 16711T QC 5/02 = LMG 16711QC4/02 = LMG 16711 QC 5/00 = Ponsonby = VPI 0389 = FIRDI 723 = strain Ponsonby
Sequences (36)
Associated Publications (41)
  • DOI: 10.1128/aem.38.4.585-589.1979
    Kishishita M, Ushijima T, Ozaki Y, Ito Y (1979). Biotyping of Propionibacterium acnes isolated from normal human facial skin.
  • DOI: 10.1016/s0939-6411(03)00137-1
    Lee TW, Kim JC, Hwang SJ (2003). Hydrogel patches containing triclosan for acne treatment.
  • DOI: 10.1099/mic.0.27788-0
    Valanne S, McDowell A, Ramage G, Tunney MM, Einarsson GG, O'Hagan S, Wisdom GB, Fairley D, Bhatia A, Maisonneuve JF, Lodes M, Persing DH, Patrick S (2005). CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II.
  • DOI: 10.1016/j.fct.2005.08.030
    Oh S, Kim SH, Ko Y, Sim JH, Kim KS, Lee SH, Park S, Kim YJ (2005). Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.
  • DOI: 10.1016/j.fct.2005.08.008
    Oh S, Kim SH, Ko Y, Sim JH, Kim KS, Lee SH, Park S, Kim YJ (2006). Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.
  • DOI: 10.1007/s12010-007-8075-1
    Deng MD, Grund AD, Schneider KJ, Langley KM, Wassink SL, Peng SS, Rosson RA (2007). Linoleic acid isomerase from Propionibacterium acnes: purification, characterization, molecular cloning, and heterologous expression.
  • DOI: 10.1248/cpb.58.27
    Tada M, Ohkanda T, Kurabe J (2010). Syntheses of carnosic acid and carnosol, anti-oxidants in Rosemary, from pisiferic acid, the major constituent of Sawara.
  • DOI: 10.1007/s00403-010-1074-z
    Lee SE, Kim JM, Jeong SK, Jeon JE, Yoon HJ, Jeong MK, Lee SH (2010). Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes.
  • DOI: 10.1021/jf404461q
    Wang L, Yang X, Yu X, Yao Y, Ren G (2013). Evaluation of antibacterial and anti-inflammatory activities of less polar ginsenosides produced from polar ginsenosides by heat-transformation.
  • DOI: 10.1128/genomeA.00740-14
    Liu J, Cheng A, Bangayan NJ, Barnard E, Curd E, Craft N, Li H (2014). Draft Genome Sequences of Propionibacterium acnes Type Strain ATCC6919 and Antibiotic-Resistant Strain HL411PA1.
  • Athikomkulchai S, Tadtong S, Ruangrungsi N, Hongratanaworakit T (2015). Chemical Composition of the Essential Oil from Croton oblongifolius and its Antibacterial Activity against Propionibacterium acnes.
  • DOI: 10.1099/ijsem.0.001204
    Aubin GG, Bemer P, Kambarev S, Patel NB, Lemenand O, Caillon J, Lawson PA, Corvec S (2016). Propionibacterium namnetense sp. nov., isolated from a human bone infection.
  • DOI: 10.1016/j.anaerobe.2017.06.008
    Moreti DLC, Leandro LF, da Silva Moraes T, Moreira MR, Sola Veneziani RC, Ambrosio SR, Gomes BP, Martins CHG (2017). Mikania glomerata Sprengel extract and its major compound ent-kaurenoic acid display activity against bacteria present in endodontic infections.
  • DOI: 10.3389/fphar.2019.01559
    De Canha MN, Komarnytsky S, Langhansova L, Lall N (2020). Exploring the Anti-Acne Potential of Impepho [Helichrysum odoratissimum (L.) Sweet] to Combat Cutibacterium acnes Virulence.
  • DOI: 10.1111/cmi.13234
    Huang X, Pan W, Kim W, White A, Li S, Li H, Lee K, Fuchs BB, Zeng K, Mylonakis E (2020). Caenorhabditis elegans mounts a p38 MAPK pathway-mediated defence to Cutibacterium acnes infection.
  • DOI: 10.1016/j.jep.2020.113552
    Wei MP, Qiu JD, Li L, Xie YF, Yu H, Guo YH, Yao WR (2020). Saponin fraction from Sapindus mukorossi Gaertn as a novel cosmetic additive: Extraction, biological evaluation, analysis of anti-acne mechanism and toxicity prediction.
  • DOI: 10.7705/biomedica.5122
    Ossa-Tabares JC, Llanos CJ, Garcia AM (2020). Evaluation of tea tree oil physicochemical features and its antimicrobial activity against Cutibacterium acnes (Propionibacterium acnes) ATCC 6919.
  • DOI: 10.4103/0973-029X.325125
    Kusugal P, Bhat KG, Ingalagi P, Patil S, Pattar G (2021). Coculture method for in vitro cultivation of uncultured oral bacteria.
  • DOI: 10.3390/antibiotics11050665
    Pichon M, Burucoa C, Evplanov V, Favalli F (2022). Efficacy of Three Povidone Iodine Formulations against Cutibacterium acnes Assessed through In Vitro Studies: A Preliminary Study.
  • DOI: 10.1128/aac.01679-22
    Huang XW, Pan W, Zhong MZ, Chhonker YS, Steele AD, Keohane CE, Mishra B, Felix Raj Lucas LO, Murry DJ, Ausubel FM, Wuest WM, Li CX, Mylonakis E (2023). Biological Evaluation of the Antibacterial Retinoid CD437 in Cutibacterium acnes Infection.
  • DOI: 10.1111/jocd.15809
    Bae WY, Jung WH, Lee YJ, Shin SL, An YK, Kim TR, Sohn M (2023). Heat-treated Pediococcus acidilactici LM1013-mediated inhibition of biofilm formation by Cutibacterium acnes and its application in acne vulgaris: A single-arm clinical trial.
  • DOI: 10.3390/microorganisms11092183
    Forraz N, Bize C, Desroches AL, Milet C, Payen P, Chanut P, Kern C, Garcia C, McGuckin C (2023). The World's First Acne Dysbiosis-like Model of Human 3D Ex Vivo Sebaceous Gland Colonized with Cutibacterium acnes and Staphylococcus epidermidis.
  • DOI: 10.1007/s12088-023-01169-3
    Coelho ALS, Laroque DA, Feuser PE, de Andrade CJ, Carciofi BAM, de Oliveira D (2023). Effects of Mannosylerythritol-Lipids-B on Cutibacterium acnes ATCC 6919.
  • DOI: 10.1016/j.euprot.2015.06.003
    Yu Y, Champer J, Kim J (2015). Analysis of the Surface, Secreted, and Intracellular Proteome of Propionibacterium acnes.
  • DOI: 10.1038/srep42918
    Aubin GG, Baud'huin M, Lavigne JP, Brion R, Gouin F, Lepelletier D, Jacqueline C, Heymann D, Asehnoune K, Corvec S (2017). Interaction of Cutibacterium ( formerly Propionibacterium) acnes with bone cells: a step toward understanding bone and joint infection development.
  • DOI: 10.1002/mabi.201700090
    Nair SS, Zolotarskaya OY, Beckwith MJ, Ohman DE, Wynne KJ (2017). A Polycation Antimicrobial Peptide Mimic without Resistance Buildup against Propionibacterium Acnes.
  • DOI: 10.1128/MRA.00705-20
    Deptula P, Laine P, Paulin L, Auvinen P, Roberts RJ, Johnston CD, Varmanen P (2020). Complete Genome Sequences and Methylome Analyses of Cutibacterium acnes subsp. acnes Strains DSM 16379 and DSM 1897(T).
  • DOI: 10.1038/s41598-024-54686-6
    Poothong S, Tanasupawat S, Chanpongsang S, Kingkaew E, Nuengjamnong C (2024). Anaerobic flora, Selenomonas ruminis sp. nov., and the bacteriocinogenic Ligilactobacillus salivarius strain MP3 from crossbred-lactating goats.
  • DOI: 10.1093/jac/49.3.455
    Yamakawa T, Mitsuyama J, Hayashi K (2002). In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.
  • DOI: 10.1007/s00253-008-1838-y
    Nakajima M, Nishimoto M, Kitaoka M (2009). Characterization of beta-1,3-galactosyl-N-acetylhexosamine phosphorylase from Propionibacterium acnes.
  • DOI: 10.1038/jid.2009.46
    Iinuma K, Sato T, Akimoto N, Noguchi N, Sasatsu M, Nishijima S, Kurokawa I, Ito A (2009). Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro.
  • DOI: 10.1016/j.jse.2020.12.009
    Kia C, Cusano A, Messina J, Muench LN, Chadayammuri V, McCarthy MB, Umejiego E, Mazzocca AD (2021). Effectiveness of topical adjuvants in reducing biofilm formation on orthopedic implants: an in vitro analysis.
  • DOI: 10.1080/00365540701632998
    Qi X, Gao J, Sun D, Liang W, Wan Y, Li C, Xu X, Gao T (2007). Biofilm formation of the pathogens of fatal bacterial granuloma after trauma: potential mechanism underlying the failure of traditional antibiotic treatments.
  • DOI: 10.1016/j.micpath.2017.02.030
    Eroshenko D, Polyudova T, Korobov V (2017). N-acetylcysteine inhibits growth, adhesion and biofilm formation of Gram-positive skin pathogens.
  • DOI: 10.1093/femsle/fnab014
    El-Mahdy TS, Mongaret C, Varin-Simon J, Lamret F, Vernet-Garnier V, Rammal H, Mauprivez C, Kerdjoudj H, Gangloff SC, Reffuveille F (2021). Interaction of implant infection-related commensal bacteria with mesenchymal stem cells: a comparison between Cutibacterium acnes and Staphylococcus aureus.
  • DOI: 10.1016/j.lfs.2014.12.029
    Jeon YM, Lee HS, Jeong D, Oh HK, Ra KH, Lee MY (2015). Antimicrobial photodynamic therapy using chlorin e6 with halogen light for acne bacteria-induced inflammation.
  • DOI: 10.3390/ijms21051717
    Hwang DH, Lee DY, Koh PO, Yang HR, Kang C, Kim E (2020). Rosa davurica Pall. Improves Propionibacterium acnes-Induced Inflammatory Responses in Mouse Ear Edema Model and Suppresses Pro-Inflammatory Chemokine Production via MAPK and NF-kappaB Pathways in HaCaT Cells.
  • DOI: 10.3390/molecules27238331
    Joo JH, Han MH, Kim JI, Kim JE, Jung KH, Oh HS, Chung YS, An HJ, Lee JD, Moon GS, Lee HY (2022). Antimicrobial Activity of Smilax china L. Root Extracts against the Acne-Causing Bacterium, Cutibacterium acnes, and Its Active Compounds.
  • DOI: 10.3390/antibiotics12061035
    Han MH, Khan SA, Moon GS (2023). Cutibacterium acnes KCTC 3314 Growth Reduction with the Combined Use of Bacteriophage PAP 1-1 and Nisin.
  • DOI: 10.1038/s41598-023-43559-z
    Kim JI, Hasnain MA, Moon GS (2023). Expression of a recombinant endolysin from bacteriophage CAP 10-3 with lytic activity against Cutibacterium acnes.
  • DOI: 10.4315/0362-028x-71.12.2523
    Chen GH, Yin LJ, Chiang IH, Jiang ST (2008). Cloning and expression of antibacterial goat lactoferricin from Escherichia coli AD494(DE3)pLysS expression system.
Outside links and data sources
Retrieved 5 months ago via StrainInfo API (CC BY 4.0)

Metadata

Cannonical URL
https://seqco.de/s:30195
Local history
  • Registered 11 months ago
  • Last modified 5 months ago
© 2022-2025 The SeqCode Initiative
  All information contributed to the SeqCode Registry is released under the terms of the Creative Commons Attribution (CC BY) 4.0 license